PlainRecalls
FDA Drug Low Class III Terminated

Testosterone Cypionate Injection, USP CIII 200mg/ml FOR INTRAMUSCULAR USE ONLY 1mL Single-dose vial Distributed by: Sun Pharma Ind. Inc, NJ 08512 Manufactured by: Sun Pharma Ind. Ltd., India NDC 62756-015-40

Reported: February 3, 2021 Initiated: January 11, 2021 #D-0242-2021

Product Description

Testosterone Cypionate Injection, USP CIII 200mg/ml FOR INTRAMUSCULAR USE ONLY 1mL Single-dose vial Distributed by: Sun Pharma Ind. Inc, NJ 08512 Manufactured by: Sun Pharma Ind. Ltd., India NDC 62756-015-40

Reason for Recall

Incorrect Labeling: Incorrect lot number on secondary packaging

Details

Units Affected
36,275 cartons
Distribution
Nationwide
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Testosterone Cypionate Injection, USP CIII 200mg/ml FOR INTRAMUSCULAR USE ONLY 1mL Single-dose vial Distributed by: Sun Pharma Ind. Inc, NJ 08512 Manufactured by: Sun Pharma Ind. Ltd., India NDC 62756-015-40. Recalled by SUN PHARMACEUTICAL INDUSTRIES INC. Units affected: 36,275 cartons.
Why was this product recalled?
Incorrect Labeling: Incorrect lot number on secondary packaging
Which agency issued this recall?
This recall was issued by the FDA Drug on February 3, 2021. Severity: Low. Recall number: D-0242-2021.